Genetic variation within IL18 is associated with insulin levels, insulin resistance and postprandial measures

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 7, 2011, Pages 476-484

  Smart, M C ^a   Dedoussis, G ^b   Yiannakouris, N ^b   Grisoni, M L ^c,d   Dror, G K ^a   Yannakoulia, M ^b   Papoutsakis, C ^b   Louizou, E ^b   Mantzoros, C S ^e   Melistas, L ^b   Kontogianni, M D ^b   Cooper, J A ^a   Humphries, S E ^a   Talmud, P J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b HAROKOPIO UNIVERSITY   (Greece)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Genetic variants; Haplotypes; Insulin resistance; Interleukin 18; Obesity; Single nucleotide polymorphisms

Indexed keywords

INSULIN; INTERLEUKIN 18; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHILD; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GREECE; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POSTPRANDIAL STATE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CHILD; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GREECE; HUMANS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-18; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTPRANDIAL PERIOD; TRIGLYCERIDES; YOUNG ADULT;

EID: 79959524219     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.12.004     Document Type: Article

References (31)

1. Dinarello C.A., Fantuzzi G. Interleukin-18 and host defense against infection. J Infect Dis 2003 Jun 15, 187(Suppl. 2):S370-S384.
2. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995 Nov 2, 378(6552):88-91.
3. Mallat Z., Corbaz A., Scoazec A., Besnard S., Leseche G., Chvatchko Y., et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001 Oct 2, 104(14):1598-1603.
4. Blankenberg S., Luc G., Ducimetiere P., Arveiler D., Ferrieres J., Amouyel P., et al. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003, 108(20):2453-2459.
5. Wood I.S., Wang B., Jenkins J.R., Trayhurn P. The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFalpha in human adipocytes. Biochem Biophys Res Commun 2005, 337(2):422-429.
6. Hung J., McQuillan B.M., Chapman C.M., Thompson P.L., Beilby J.P. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol. 2005, 25(6):1268-1273.
7. Skurk T., Kolb H., Muller-Scholze S., Rohrig K., Hauner H., Herder C. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol 2005, 152(6):863-868.
8. Straczkowski M., Kowalska I., Nikolajuk A., Otziomek E., Adamska A., Karolczuk-Zarachowicz M., et al. Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance. Int J Obes (Lond) 2006.
9. Van Guilder G.P., Hoetzer G.L., Greiner J.J., Stauffer B.L., Desouza C.A. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity (Silver Spring, Md) 2006 Dec, 14(12):2127-2131.
10. Bruun J.M., Stallknecht B., Helge J.W., Richelsen B. Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol/Eur Federation Endocrine Soc 2007 Oct, 157(4):465-471.
11. Thorand B., Kolb H., Baumert J., Koenig W., Chambless L., Meisinger C., et al. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes 2005 Oct, 54(10):2932-2938.
12. Fischer C.P., Perstrup L.B., Berntsen A., Eskildsen P., Pedersen B.K. Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans. Clin Immunol (Orlando, Fla) 2005 Nov, 117(2):152-160.
13. Netea M.G., Joosten L.A., Lewis E., Jensen D.R., Voshol P.J., Kullberg B.J., et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 2006 Jun, 12(6):650-656.
14. Zorrilla E.P., Sanchez-Alavez M., Sugama S., Brennan M., Fernandez R., Bartfai T., et al. Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci USA 2007 Jun 26, 104(26):11097-11102.
15. Thompson S.R., Sanders J., Stephens J.W., Miller G.J., Humphries S.E. A common interleukin 18 haplotype is associated with higher body mass index in subjects with diabetes and coronary heart disease. Metabolism 2007 May, 56(5):662-669.
16. Presta I., Andreozzi F., Succurro E., Marini M.A., Laratta E., Lauro R., et al. IL-18 gene polymorphism and metabolic syndrome. Nutr Metab Cardiovasc Dis 2009 Feb, 19(2):e5-e6.
17. Papoutsakis C., Vidra N.V., Hatzopoulou I., Tzirkalli M., Farmaki A.E., Evagelidaki E., et al. The Gene-Diet Attica investigation on childhood obesity (GENDAI): overview of the study design. Clin Chem Lab Med 2007, 45(3):309-315.
18. Tiret L., Gerdes C., Murphy M.J., Dallongeville J., Nicaud V., O'Reilly D.S., et al. Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease - the EARS II study (European Atherosclerosis Research Study). Eur J Clin Invest 2000 Jul, 30(7):578-585.
19. Yannakoulia M., Yiannakouris N., Melistas L., Fappa E., Vidra N., Kontogianni M.D., et al. Dietary factors associated with plasma high molecular weight and total adiponectin levels in apparently healthy women. Eur J Endocrinol/Eur Federation Endocrine Soc 2008 Oct, 159(4):R5-10.
20. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 Jul, 28(7):412-419.
21. Bermudez V., Cano R., Cano C., Bermudez F., Leal E., Acosta K., et al. Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes. Am J Therapeutics 2008 Jul-Aug, 15(4):409-416.
22. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000 Jul, 85(7):2402-2410.
23. Tregouet D.A., Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics (Oxford, England) 2007 Apr 15, 23(8):1038-1039.
24. Scheet P., Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Human Genet 2006 Apr, 78(4):629-644.
25. Thompson S.R., McCaskie P.A., Beilby J.P., Hung J., Jennens M., Chapman C., et al. IL18 Haplotypes are associated with serum IL-18 concentrations in a population-based study and a cohort of individuals with premature coronary heart disease. Clin Chem 2007 Oct 25.
26. Tiret L., de Knijff P., Menzel H.J., Ehnholm C., Nicaud V., Havekes L.M. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb 1994 Oct, 14(10):1617-1624.
27. Mensah F.K., Gilthorpe M.S., Davies C.F., Keen L.J., Adamson P.J., Roman E., et al. Haplotype uncertainty in association studies. Genet Epidemiol 2007 May, 31(4):348-357.
28. Liang X.H., Cheung W., Heng C.K., Wang D.Y. Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study. Biochem Biophys Res Commun 2005 Dec 16, 338(2):736-741.
29. Tiret L., Godefroy T., Lubos E., Nicaud V., Tregouet D.A., Barbaux S., et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005 Aug 2, 112(5):643-650.
30. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004 Mar, 27(3):813-823.
31. Biondi-Zoccai G.G., Abbate A., Liuzzo G., Biasucci L.M. Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol 2003 Apr 2, 41(7):1071-1077.